Ccl24 - chemokine (C-C motif) ligand 24 Gene
Also Known as CKb-6; MPIF-2; Scya24
Species: Mus musculus
Summary
Enables cytokine activity. Involved in positive regulation of angiogenesis and positive regulation of inflammatory response. Acts upstream of or within chemotaxis and positive regulation of eosinophil migration. Predicted to be located in extracellular region. Predicted to be active in extracellular space. Human ortholog(s) of this gene implicated in asthma and rhinitis. Orthologous to human CCL24 (C-C motif chemokine ligand 24). [provided by Alliance of Genome Resources, Apr 2022]
Ccl24 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001356630.1 | NP_001343559.1 | C-C motif chemokine 24 precursor |
| NM_019577.5 | NP_062523.1 | C-C motif chemokine 24 precursor |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables cytokine activity |
IDA
IDA: Inferred from direct assay
|
11067944 | MGI |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| acts upstream of or within chemotaxis |
IDA
IDA: Inferred from direct assay
|
11067944 | MGI |
| involved in positive regulation of angiogenesis |
IMP
IMP: Inferred from mutant phenotype
|
19525930 | MGI |
| acts upstream of or within positive regulation of eosinophil migration |
IMP
IMP: Inferred from mutant phenotype
|
15647285 | MGI |
| involved in positive regulation of inflammatory response |
IMP
IMP: Inferred from mutant phenotype
|
19841166 | MGI |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
C-C motif chemokine 24 |
|
|
Recombinant Ccl24 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P7760 | CCL24/Eotaxin-2 Protein, Mouse | Q9JKC0 (V27-V119) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P78248 | CCL24/Eotaxin-2 Protein, Mouse (HEK293, His) | Q9JKC0 (V27-V119) | ≥ 95%, as determined by Bis-Tris PAGE. |
| HY-P78250 | CCL24/Eotaxin-2 Protein, Mouse (HEK293, Fc) | Q9JKC0 (V27-V119) | ≥ 95%, as determined by Bis-Tris PAGE. |